Commentary - (2018) Volume 4, Issue 2
Second Generation Long-Acting Antipsychotics in the Treatment of Bipolar Disorder: A Clinical Viewpoint
- De Berardis D1,2*, Fornaro M3,4, Orsolini L3,4,5, Vellante F1,2, Carano A6, Valchera A3,4,5,6,7, Tomasetti C3,4,5,6,7,8, Martinotti G2 and Di Giannantonio M2
- 1NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", ASL 4 Teramo, Italy
- 2Department of Neurosciences and Imaging, Chair of Psychiatry, University "G. d'Annunzio", Chieti, Italy
- 3Polyedra Research Group, Teramo, Italy
- 4Section of Psychiatry, Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University, Naples, Italy
- 5School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Herts, UK
- 6NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "Madonna Del Soccorso", NHS, San Benedetto del Tronto, Ascoli Piceno, Italy
- 7Villa S. Giuseppe Hospital, Hermanas Hospitalarias, Ascoli Piceno, Italy
- 8NHS, Department of Mental Health ASL Teramo, Psychiatric Service of Diagnosis and Treatment, Hospital "Maria SS dello Splendore", ASL 4 Giulianova, Italy
*Corresponding Author:
De Berardis D, National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", Piazza Italia 1, 64100 Teramo, Italy, Tel: +39 0861429708
Email: